SCHEMBL23020744

SCHEMBL23020744

Fc1ccc(Nc2ncc3c(n2)CNC3)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.51
CCNA2 P20248 3/20 0.46
CDK2 P24941 3/20 0.46
CDK5 Q00535 3/20 0.46
CDK5R1 Q15078 3/20 0.46
GRM5 P41594 1/20 0.46
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
MEN1 O00255 2/20 0.45
MAPT P10636 2/20 0.45
KMT2A Q03164 2/20 0.45
MAPK1 P28482 2/20 0.45
LMNA P02545 1/20 0.45
ALOX12 P18054 1/20 0.45
CDC7 O00311 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
ALDH1A1 P00352 1/20 0.44
TSHR P16473 1/20 0.44
HTT P42858 1/20 0.44
CDK4 P11802 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23000039 0.99 AURKA (0.50) AURKACCNA2CDK2CDK5CDK5R1
SCHEMBL9959309 0.87 CDK5 (0.49) AURKACCNA2CDK2CDK5CDK5R1
SCHEMBL23000040 0.85 AXL (0.42) CCNA2CDK2CDK5CDK5R1GRM5
SCHEMBL23021156 0.85 CDK2 (0.63) AURKACCNA2CDK2CDK5CDK5R1
SCHEMBL17106477 0.85 CDK5 (0.61) AURKACCNA2CDK2CDK5CDK5R1
SCHEMBL23021273 0.85 TP53 (0.43) AURKACCNA2CDK2CDK5CDK5R1
SCHEMBL22999553 0.85 CDK2 (0.55) AURKACCNA2CDK2CDK5CDK5R1
Hydrochloric Acid SCHEMBL22999614 0.84 CDK2 (0.62) AURKACCNA2CDK2CDK5CDK5R1
Hydrochloric Acid SCHEMBL22999918 0.84 GRM5 (0.62) CCNA2CDK2CDK5CDK5R1GRM5
Hydrochloric Acid SCHEMBL22999742 0.84 CDK5 (0.60) AURKACCNA2CDK2CDK5CDK5R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021032323-A1 FUSED PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROTIC DISEASES GALAPAGOS NV (BE) 2021-02-25 WO disclosed
EP-3782997-A1 FUSED PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROTIC DISEASES Galapagos N.V. (BE) 2021-02-24 EP disclosed